Landmark trial
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Catton CN, Lukka H, Gu CS, et al.
DoseLab summary
Citation as given in the eviQ reference list; not yet checked against the journal.
Why this is useful
Phase 3 trial (PROFIT) supporting 60 Gy in 20 fractions for intermediate-risk prostate cancer.
Reference details
- Title
- Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
- Authors / organization
- Catton CN, Lukka H, Gu CS, et al.
- Publication / protocol
- J Clin Oncol. 2017;35(17):1884–1890
- Version
- Pending verification
- Year
- 2017
- DOI
- Pending verification
- Disease sites
- Prostate
- Topics
- Prostate, Hypofractionation, Landmark trial
- Fractionation context
- Moderate hypofractionation vs conventional
- Last reviewed by DoseLab
- Pending verification